Evidence map›Paper›PMID 28851980›Full record

ArticleScientific reports2017

Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential.

Michael A Bellio, Mariana T Pinto, Victoria Florea, Paola A Barrios, Christy N Taylor, Ariel B Brown, Courtney Lamondin, Joshua M Hare, Ivonne H Schulman, Claudia O Rodrigues

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. MYC: there is more to it than cancer.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Michael A BellioInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Mariana T PintoInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Victoria FloreaInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Paola A BarriosInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Christy N TaylorInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Ariel B BrownInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Courtney LamondinInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Joshua M HareInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0002-7751-5032
Ivonne H SchulmanInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Claudia O RodriguesInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America. crodrigues@miami.edu.
University of Miami · US

Funding

Cell Based Therapy for Non-Ischemic Dilated CardiomyopathyUM1HL113460 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2012 to 2018
$4.3M
Cellular Cardiomyoplasty for Chronic Heart FailureR01HL084275 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2007 to 2016
$3.8M
Mesenchymal stem cell therapy for endothelial dysfunction in diabetesR01HL134558 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2016 to 2020
$3.2M
Nitric Oxide and sex differences in cardiac repairR01HL137355 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2017 to 2020
$1.6M
Molecular Mechanisms of Stem Cell EngraftmentK01HL103184 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RODRIGUES, CLAUDIA OLIVEIRA · 2010 to 2014
$664k
A Novel Role for cMyc in the Control of Vascular Response to StressR03HL133638 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RODRIGUES, CLAUDIA OLIVEIRA · 2016 to 2017
$154k
Howard Hughes Medical InstituteNHLBI NIH HHS K01 HL103184NHLBI NIH HHS R01 HL084275NHLBI NIH HHS R01 HL134558NHLBI NIH HHS R01 HL137355NHLBI NIH HHS R03 HL133638NHLBI NIH HHS UM1 HL113460
6 · The paper itself

Abstract

Cardiac progenitor cells (CPCs) have been shown to promote cardiac regeneration and improve heart function. However, evidence suggests that their regenerative capacity may be limited in conditions of severe hypoxia. Elucidating the mechanisms involved in CPC protection against hypoxic stress is essential to maximize their cardioprotective and therapeutic potential. We investigated the effects of hypoxic stress on CPCs and found significant reduction in proliferation and impairment of vasculogenesis, which were associated with induction of quiescence, as indicated by accumulation of cells in the G0-phase of the cell cycle and growth recovery when cells were returned to normoxia. Induction of quiescence was associated with a decrease in the expression of c-Myc through mechanisms involving protein degradation and upregulation of p21. Inhibition of c-Myc mimicked the effects of severe hypoxia on CPC proliferation, also triggering quiescence. Surprisingly, these effects did not involve changes in p21 expression, indicating that other hypoxia-activated factors may induce p21 in CPCs. Our results suggest that hypoxic stress compromises CPC function by inducing quiescence in part through downregulation of c-Myc. In addition, we found that c-Myc is required to preserve CPC growth, suggesting that modulation of pathways downstream of it may re-activate CPC regenerative potential under ischemic conditions.

Indexed as

Cell CycleNeovascularization, PhysiologicStress, PhysiologicalAnimalsCell DifferentiationCell ProliferationCell SurvivalCellular SenescenceGene ExpressionGlycogen Synthase Kinase 3 betaHypoxiaMiceMyocytes, CardiacProtein StabilityProto-Oncogene Proteins c-mycGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-myc

Identifiers

PMID28851980
PMCPMC5575078
OpenAlexW2746578261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.